Immunoproteasome and Non-Covalent Inhibition: Exploration by Advanced Molecular Dynamics and Docking Methods

The selective inhibition of immunoproteasome is a valuable strategy to treat autoimmune, inflammatory diseases, and hematologic malignancies. Recently, a new series of amide derivatives as non-covalent inhibitors of the β1i subunit with <i>K</i><sub>i</sub> values in the low/...

Full description

Bibliographic Details
Main Authors: Giulia Culletta, Maria Zappalà, Roberta Ettari, Anna Maria Almerico, Marco Tutone
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/26/13/4046